Eli Lilly & Co. stock outperforms competitors on strong trading day
Shares of Eli Lilly & Co. LLY advanced 1.69% to $813.33 Tuesday, on what proved to be an all-around mixed trading session for ...
Reuters on MSN51m
Eli Lilly's weight loss drug powers long-term growth, CIO says
Adam Coons, chief investment officer at Winthrop Capital Management, says Eli Lilly's weight loss drug is positioning the company for continued growth, as the need "to mitigate obesity" is not going ...